Nick N. Gorgani

1.6k total citations
21 papers, 966 citations indexed

About

Nick N. Gorgani is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nick N. Gorgani has authored 21 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nick N. Gorgani's work include Complement system in diseases (7 papers), Phagocytosis and Immune Regulation (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Nick N. Gorgani is often cited by papers focused on Complement system in diseases (7 papers), Phagocytosis and Immune Regulation (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Nick N. Gorgani collaborates with scholars based in Australia, United States and Thailand. Nick N. Gorgani's co-authors include Joseph G. Altin, Karim Y. Helmy, Kenneth J. Katschke, Menno van Lookeren Campagne, Lauri Diehl, J. Michael Elliott, Nico Ghilardi, Suzie J. Scales, Noelyn M. Kljavin and Christopher R. Parish and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Nick N. Gorgani

20 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick N. Gorgani Australia 15 513 298 118 118 90 21 966
M Rits United States 15 534 1.0× 424 1.4× 106 0.9× 72 0.6× 84 0.9× 16 1.0k
Satoshi Tanaka Japan 6 728 1.4× 229 0.8× 80 0.7× 96 0.8× 41 0.5× 7 1.1k
Dale R. Taylor United Kingdom 9 892 1.7× 522 1.8× 144 1.2× 229 1.9× 78 0.9× 12 1.6k
Andy Tsun China 18 943 1.8× 420 1.4× 108 0.9× 52 0.4× 76 0.8× 28 1.5k
Marı́a Simarro Spain 23 969 1.9× 626 2.1× 116 1.0× 188 1.6× 120 1.3× 55 1.8k
Toshihiko Kobayashi Japan 14 871 1.7× 436 1.5× 144 1.2× 102 0.9× 63 0.7× 38 1.3k
Lap-Ping Chung United Kingdom 21 585 1.1× 423 1.4× 82 0.7× 233 2.0× 93 1.0× 27 1.4k
Martine Humbert France 12 598 1.2× 457 1.5× 96 0.8× 52 0.4× 46 0.5× 15 1.2k
David W. LaFleur United States 17 531 1.0× 402 1.3× 129 1.1× 46 0.4× 34 0.4× 22 1.2k
Suman Mitra France 19 937 1.8× 367 1.2× 120 1.0× 83 0.7× 88 1.0× 28 1.4k

Countries citing papers authored by Nick N. Gorgani

Since Specialization
Citations

This map shows the geographic impact of Nick N. Gorgani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick N. Gorgani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick N. Gorgani more than expected).

Fields of papers citing papers by Nick N. Gorgani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick N. Gorgani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick N. Gorgani. The network helps show where Nick N. Gorgani may publish in the future.

Co-authorship network of co-authors of Nick N. Gorgani

This figure shows the co-authorship network connecting the top 25 collaborators of Nick N. Gorgani. A scholar is included among the top collaborators of Nick N. Gorgani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick N. Gorgani. Nick N. Gorgani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Odell, Luke R., Nigel C. Jones, Ngoc Chau, et al.. (2023). The sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models. RSC Medicinal Chemistry. 14(8). 1492–1511. 3 indexed citations
2.
Vitetta, Luis, et al.. (2023). Prebiotics Progress Shifts in the Intestinal Microbiome That Benefits Patients with Type 2 Diabetes Mellitus. Biomolecules. 13(9). 1307–1307. 17 indexed citations
4.
Perveen, Khalida, et al.. (2019). Human Dendritic Cells Express the Complement Receptor Immunoglobulin Which Regulates T Cell Responses. Frontiers in Immunology. 10. 2892–2892. 14 indexed citations
6.
Ma, Yuefang, Kanchana Usuwanthim, Nick N. Gorgani, et al.. (2015). Protein Kinase Cα Regulates the Expression of Complement Receptor Ig in Human Monocyte–Derived Macrophages. The Journal of Immunology. 194(6). 2855–2861. 18 indexed citations
7.
Lees, Justin G., Nick N. Gorgani, Alaina J. Ammit, et al.. (2014). Role of dynamin in elongated cell migration in a 3D matrix. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(3). 611–618. 10 indexed citations
8.
Gorgani, Nick N., et al.. (2011). Regulation of CRIg Expression and Phagocytosis in Human Macrophages by Arachidonate, Dexamethasone, and Cytokines. American Journal Of Pathology. 179(3). 1310–1318. 30 indexed citations
9.
Hill, Timothy A., Anna Mariana, Christopher P. Gordon, et al.. (2010). Iminochromene Inhibitors of Dynamins I and II GTPase Activity and Endocytosis. Journal of Medicinal Chemistry. 53(10). 4094–4102. 53 indexed citations
10.
Odell, Luke R., Christopher P. Gordon, Mark J. Robertson, et al.. (2010). The Pthaladyns: GTP Competitive Inhibitors of Dynamin I and II GTPase Derived from Virtual Screening. Journal of Medicinal Chemistry. 53(14). 5267–5280. 43 indexed citations
11.
Gorgani, Nick N. & Argyrios N. Theofilopoulos. (2007). Contribution of histidine-rich glycoprotein in clearance of immune complexes and apoptotic cells: Implications for ameliorating autoimmune diseases. Autoimmunity. 40(4). 260–266. 12 indexed citations
12.
Gorgani, Nick N., Yan Ma, & Hilary Clark. (2007). Gene signatures reflect the marked heterogeneity of tissue‐resident macrophages. Immunology and Cell Biology. 86(3). 246–254. 19 indexed citations
13.
Helmy, Karim Y., Kenneth J. Katschke, Nick N. Gorgani, et al.. (2006). CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens. Cell. 124(5). 915–927. 446 indexed citations
14.
Gorgani, Nick N., Bruce A. Smith, Dwight H. Kono, & Argyrios N. Theofilopoulos. (2002). Histidine-Rich Glycoprotein Binds to DNA and FcγRI and Potentiates the Ingestion of Apoptotic Cells by Macrophages. The Journal of Immunology. 169(9). 4745–4751. 45 indexed citations
15.
Gorgani, Nick N., Christopher R. Parish, & Joseph G. Altin. (1999). Differential Binding of Histidine-rich Glycoprotein (HRG) to Human IgG Subclasses and IgG Molecules Containing κ and λ Light Chains. Journal of Biological Chemistry. 274(42). 29633–29640. 39 indexed citations
16.
Gorgani, Nick N., Joseph G. Altin, & Christopher R. Parish. (1999). Histidine-rich glycoprotein regulates the binding of monomeric IgG and immune complexes to monocytes. International Immunology. 11(8). 1275–1282. 28 indexed citations
17.
Gorgani, Nick N., Joseph G. Altin, & Christopher R. Parish. (1999). Histidine‐rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor. Immunology. 98(3). 456–463. 23 indexed citations
18.
Hall, Damien, Nick N. Gorgani, Joseph G. Altin, & Donald J. Winzor. (1997). Theoretical and Experimental Considerations of the Pseudo-First-Order Approximation in Conventional Kinetic Analysis of IAsys Biosensor Data. Analytical Biochemistry. 253(2). 145–155. 20 indexed citations
19.
Gorgani, Nick N., et al.. (1997). Histidine-Rich Glycoprotein Binds to Human IgG and C1q and Inhibits the Formation of Insoluble Immune Complexes. Biochemistry. 36(22). 6653–6662. 69 indexed citations
20.
Gorgani, Nick N., Simon B. Easterbrook‐Smith, & Joseph G. Altin. (1996). The formation of insoluble immune complexes between ovalbumin and anti-ovalbumin IgG occurs in at least two distinct phases dependent on reactant concentration and ionic strength. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1317(1). 45–54. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026